6091 - 6100 of 8093 Results
Title
Year
-
RESTRICTEDTitle: Microglial phenotypes in Parkinson’s disease and animal models of the diseaseJournal Name: Progress in NeurobiologyPublisher: Elsevier BVVol: 155Issue #:Start Page: 57End Page: 75Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.pneurobio.2016.04.006Best OA location URL: https://europepmc.org/articles/pmc5073045?pdf=renderCitation Count: 207
-
OPENTitle: mzStudio: A Dynamic Digital Canvas for User-Driven Interrogation of Mass Spectrometry DataJournal Name: ProteomesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 20End Page: 20Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/proteomes5030020Best OA location URL: https://www.mdpi.com/2227-7382/5/3/20/pdf?version=1501590909Citation Count: 23
-
RESTRICTEDTitle: The role of neurotransmitters in the development of Parkinson's disease‐related psychosisJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 10Start Page: 1244End Page: 1254Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ene.13376Citation Count: 48
- Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementia2017OPENTitle: Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer’s disease core biomarkers in Lewy body disorders and Alzheimer’s dementiaJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-017-0276-4Best OA location URL: https://alzres.biomedcentral.com/track/pdf/10.1186/s13195-017-0276-4Citation Count: 114
- Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling Analysis2017OPENTitle: Dopamine Transporter Neuroimaging as an Enrichment Biomarker in Early Parkinson's Disease Clinical Trials: A Disease Progression Modeling AnalysisJournal Name: Clinical and Translational SciencePublisher: WileyVol: 11Issue #: 1Start Page: 63End Page: 70Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1111/cts.12492Best OA location URL: https://doi.org/10.1111/cts.12492Citation Count: 42
- Parkinson disease–associatedLRRK2 G2019Stransgene disrupts marrow myelopoiesis and peripheral Th17 response2017